Satellos Bioscience announced submission of a clinical research proposal to a Human Research Ethics Committee, or HREC, in Australia seeking regulatory authorization under their Therapeutic Goods Administration’s, or TGA’s, clinical trial notification, or CTN, scheme to conduct a first-in-human Phase 1 clinical trial of SAT-3247.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MSCLF: